PortfoliosLab logoPortfoliosLab logo
ETON vs. ACET
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ETON vs. ACET - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Eton Pharmaceuticals Inc (ETON) and Adicet Bio, Inc. (ACET). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ETON achieves a 174.51% return, which is significantly higher than ACET's 8.19% return.


ETON

1D
-5.32%
1M
23.79%
6M
209.26%
YTD
174.51%
1Y
228.52%
3Y*
154.38%
5Y*
55.29%
10Y*
ALL TIME*
29.32%

ACET

1D
0.55%
1M
1.22%
6M
14.02%
YTD
8.19%
1Y
-15.09%
3Y*
-39.17%
5Y*
-40.13%
10Y*
ALL TIME*
-47.19%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$756.90K$791.48K$803.23K
$26.85M$22.65M$16.80M

ETON vs. ACET - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
ETON
Eton Pharmaceuticals Inc
174.51%26.95%204.11%55.32%-34.27%-47.23%12.92%17.65%-4.23%
ACET
Adicet Bio, Inc.
8.19%-45.30%-49.10%-78.86%-48.89%24.48%34.71%-82.71%-23.72%

Correlation

The correlation between ETON and ACET is 0.13, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.13

Correlation (3Y)
Balances recent behavior with more history.

0.13

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.18

Correlation (All Time)
Calculated using the full available price history since Nov 13, 2018

0.17

Fundamentals

Market Cap

ETON:

$1.27B

ACET:

$85.16M

EPS

ETON:

-$0.05

ACET:

-$14.00

PB Ratio

ETON:

47.83

ACET:

0.70

Total Revenue (TTM)

ETON:

$86.93M

ACET:

$0.00

Gross Profit (TTM)

ETON:

$47.61M

ACET:

-$1.47M

EBITDA (TTM)

ETON:

$5.70M

ACET:

-$110.77M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ETON vs. ACET — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

ETON
ETON Risk / Return Rank: 9797
Overall Rank
ETON Sharpe Ratio Rank: 9999
Sharpe Ratio Rank
ETON Sortino Ratio Rank: 9797
Sortino Ratio Rank
ETON Omega Ratio Rank: 9797
Omega Ratio Rank
ETON Calmar Ratio Rank: 9797
Calmar Ratio Rank
ETON Martin Ratio Rank: 9494
Martin Ratio Rank

ACET
ACET Risk / Return Rank: 3636
Overall Rank
ACET Sharpe Ratio Rank: 3434
Sharpe Ratio Rank
ACET Sortino Ratio Rank: 3838
Sortino Ratio Rank
ACET Omega Ratio Rank: 3737
Omega Ratio Rank
ACET Calmar Ratio Rank: 3636
Calmar Ratio Rank
ACET Martin Ratio Rank: 3737
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

ETON vs. ACET - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Eton Pharmaceuticals Inc (ETON) and Adicet Bio, Inc. (ACET). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ETONACETDifference
Sharpe ratioReturn per unit of total volatility

+4.34

Sortino ratioReturn per unit of downside risk

+4.02

Omega ratioGain probability vs. loss probability

1.55

1.02

+0.53

Calmar ratioReturn relative to maximum drawdown

6.34

-0.27

+6.61

Martin ratioReturn relative to average drawdown

13.13

-0.38

+13.51

ETON vs. ACET - Sharpe Ratio Comparison

The current ETON Sharpe Ratio is 4.12, which is higher than the ACET Sharpe Ratio of -0.23. The chart below compares the historical Sharpe Ratios of ETON and ACET, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ETON vs. ACET - Drawdown Comparison

The maximum ETON drawdown since its inception was -79.94%, smaller than the maximum ACET drawdown of -99.74%. Use the drawdown chart below to compare losses from any high point for ETON and ACET.


Loading charts...

Drawdown Indicators


ETONACETDifference

Max Drawdown

Largest peak-to-trough decline

-79.94%

-99.74%

+19.80%

Max Drawdown (1Y)

Largest decline over 1 year

-36.17%

-63.28%

+27.11%

Max Drawdown (3Y)

Largest decline over 3 years

-45.65%

-88.93%

+43.28%

Max Drawdown (5Y)

Largest decline over 5 years

-69.35%

-98.20%

+28.85%

Current Drawdown

Current decline from peak

-5.32%

-99.61%

+94.29%

Average Drawdown

Average peak-to-trough decline

-36.98%

-85.60%

+48.62%

Ulcer Index

Depth and duration of drawdowns from previous peaks

17.44%

44.58%

-27.14%

Volatility

ETON vs. ACET - Volatility Comparison

Eton Pharmaceuticals Inc (ETON) and Adicet Bio, Inc. (ACET) have volatilities of 20.28% and 19.70%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ETONACETDifference

Volatility (1M)

Calculated over the trailing 1-month period

20.28%

19.70%

+0.58%

Volatility (6M)

Calculated over the trailing 6-month period

43.44%

50.19%

-6.75%

Volatility (1Y)

Calculated over the trailing 1-year period

55.80%

74.88%

-19.08%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

63.59%

90.94%

-27.35%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

63.81%

93.37%

-29.56%

Dividends

ETON vs. ACET - Dividend Comparison

Neither ETON nor ACET has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

ETON vs. ACET - Financials Comparison

This section allows you to compare key financial metrics between Eton Pharmaceuticals Inc and Adicet Bio, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


ETON and ACET have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ETON has higher volatility (20.28%) compared to ACET (19.70%). In terms of maximum drawdown, ETON dropped -79.94% vs ACET's -99.74%.

ETON currently has the higher Sharpe Ratio (4.12 vs -0.23), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ETON and ACET

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer